MedPath

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Conditions
To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
Registration Number
NCT01546376
Lead Sponsor
Rajavithi Hospital
Brief Summary

Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age 18-65 years
  • HIV positive cancer patients
  • Photon beam RT, conventional fraction >= 4000 cgy in 4 weeks
Exclusion Criteria
  • CD4 count < 200 cell/ml and not received anti retro viral

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rajavithi Hospital

🇹🇭

Bangkok, Thailand

Rajavithi Hospital
🇹🇭Bangkok, Thailand
Pathomphorn Siraprapasiri, MD
Contact
66-89-6662960
spathomphorn@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.